Regulators Say New Melanoma Drug is ‘Breakthrough’

Wednesday, 24 Apr 2013 04:50 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink
U.S. regulators have granted Merck & Co.'s experimental treatment for advanced melanoma a "breakthrough therapy" designation, which could speed development and regulatory review of the product.
 
The medicine, whose chemical name is lambrolizumab, is also being tested against other forms of cancer. It belongs to a promising class of therapies that harness the body's immune system to find and attack cancer cells. It targets a protein called PD-1, or Programmed Death receptor.
 
The FDA created the "breakthrough therapy" designation earlier this year for medicines deemed likely to demonstrate "substantial improvement" over existing drugs.
 
Although it is intended to provide an easier path for drug development, Merck said it was not yet clear what specific benefits the designation would afford.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Smoking Falls to All-Time Low

Wednesday, 26 Nov 2014 12:11 PM

The percentage of Americans who are smokers has fallen to an all-time low, now representing just 17.8 percent of the pop . . .

Fat to Blame for Half Million Cancer Cases a Year: Researchers

Wednesday, 26 Nov 2014 08:13 AM

Some half a million cases of cancer a year are due to people being overweight or obese, and the problem is particularly  . . .

Selenium Found to Boost Cancer Treatment

Tuesday, 25 Nov 2014 16:50 PM

Selenium - naturally found in such foods as garlic and- may help in the fight against certain types of cancer, a new stu . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved